- Home
- WHWK vs BZAI Comparison
WHWK vs BZAI Comparison
Compare WHWK & BZAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WHWK | BZAI |
|---|---|---|
| Founded | 2007 | 2010 |
| Country | United States | United States |
| Employees | 23 | 254 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.4M | 268.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WHWK | BZAI |
|---|---|---|
| Price | $4.04 | $1.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $7.50 | $4.67 |
| AVG Volume (30 Days) | 442.8K | ★ 7.0M |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $239.02 |
| Revenue Next Year | N/A | $45.85 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.57 | $1.00 |
| 52 Week High | $5.50 | $6.76 |
Technical Indicators
Market Signals| Indicator | WHWK | BZAI |
|---|---|---|
| Relative Strength Index (RSI) | 45.00 | 43.29 |
| Support Level | $3.72 | $1.03 |
| Resistance Level | $4.38 | $1.57 |
| Average True Range (ATR) | 0.33 | 0.17 |
| MACD | -0.07 | -0.00 |
| Stochastic Oscillator | 6.80 | 21.17 |
Price Performance
Historical ComparisonAbout WHWK Whitehawk Therapeutics Inc.
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
About BZAI Blaize Holdings Inc.
Blaize Holdings Inc provides transformative artificial intelligence (AI)-enabled edge computing solutions comprised of both its proprietary hardware and software, and third-party hardware solutions. Its portfolio includes programmable AI processors in various form factors, which can be deployed across sectors such as smart cities, defense, retail, and enterprise markets. The company operates as a single operating and reportable segment. The majority of the company's revenue is derived from Hardware revenue, which includes the sale of its semiconductor products and/or third-party hardware products that support semiconductor products through various supply agreements. Geographically, it generates the maximum revenue from China.